Literature DB >> 1689473

The effects of substance P and calcitonin gene-related peptide on the efflux of endogenous glutamate and aspartate from the rat spinal dorsal horn in vitro.

I Kangrga1, J S Larew, M Randic.   

Abstract

Bath applied SP (2 x 10(-7) to 5 x 10(-7) M) produced a significant increase in the concentration of glutamate in the spinal slice perfusate, whereas the efflux of aspartate increased only with a higher concentration of SP (5 x 10(-6) M). The enhancement of the basal efflux of glutamate persisted in the absence of external Ca2+, but the effect was blocked by (D-Arg1, D-Pro2, D-Trp7,9, Leu11)-SP, a SP analogue claimed to be an antagonist of synthetic SP. Calcitonin gene-related peptide (CGRP 10(-7) M) produced a significant increase in the concentrations of glutamate and aspartate in the perfusate. Neonatal capsaicin treatment prevented the SP-induced increase in the release of glutamate. In contrast, the effect of CGRP was not significantly modified by the capsaicin treatment. These results indicate that SP and CGRP are capable of modulating the basal efflux of endogenous aspartate and glutamate and this modulation may represent one of the mechanisms by which these peptides contribute to primary afferent synaptic transmission.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689473     DOI: 10.1016/0304-3940(90)90723-m

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

1.  Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists.

Authors:  K J Powell; W Ma; M Sutak; H Doods; R Quirion; K Jhamandas
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

2.  Chapter 9 The dorsal horn and hyperalgesia.

Authors:  Karin N Westlund
Journal:  Handb Clin Neurol       Date:  2006

Review 3.  Inflammation in acute CNS injury: a focus on the role of substance P.

Authors:  F Corrigan; R Vink; R J Turner
Journal:  Br J Pharmacol       Date:  2015-05-12       Impact factor: 8.739

4.  Excitatory amino acid profiles of synovial fluid from patients with arthritis.

Authors:  T McNearney; D Speegle; N Lawand; J Lisse; K N Westlund
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

5.  Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior.

Authors:  Marc J Marino; Tetsuji Terashima; Joanne J Steinauer; Kelly A Eddinger; Tony L Yaksh; Qinghao Xu
Journal:  Pain       Date:  2013-12-11       Impact factor: 6.961

Review 6.  Neurotransmitters in subcortical somatosensory pathways.

Authors:  J Broman
Journal:  Anat Embryol (Berl)       Date:  1994-03

7.  Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance.

Authors:  K J Powell; A Hosokawa; A Bell; M Sutak; B Milne; R Quirion; K Jhamandas
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

8.  GABA, glutamate and substance P-like immunoreactivity release: effects of novel GABAB antagonists.

Authors:  H Teoh; M Malcangio; N G Bowery
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

9.  Modulation of excitatory amino acid responses by tachykinins and selective tachykinin receptor agonists in the rat spinal cord.

Authors:  M J Cumberbatch; B A Chizh; P M Headley
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

10.  Neurotransmitters in the spinal cord dorsal horn in a model of painful neuropathy and in nerve crush.

Authors:  C Sommer; R R Myers
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.